$item.Name

首页>试剂标物>常用实验试剂>普通试剂

Human IGF-I ELISA试剂盒 Mediagnost

型号
参数
供货周期:现货 货号:E20 应用领域:医疗卫生
北京科瑞美科技有限公司

免费会员 

代理商

该企业相似产品

Mouse/ Rat IGF-1 EIA

在线询价
eBioscience公司产品,德国欧蒙诊断试剂盒,妇科检测试剂盒,美国Raybiotech公司产品,Invitrogen公司产品Millipore公司产品BD公司产品,Santa

  北京科瑞美科技有限公司是一家专门从事临床实验室诊断产品销售及售后服务的企业。经过几年的不懈努力,得到广大用户的肯定与支持。


  科瑞美公司以引进“新产品、新技术”为己任,目前已拥有四十多家国外品牌,产品涉及重组蛋白、抗体、细胞因子、骨代谢、传染病、肿瘤、激素、心肌标志物、糖尿病、自身免疫、蛋白质芯片、优生优育等众多领域。相当多的产品和相关技术在国内的推广与国外几乎是同步的,为广大的科研工作者提供了有力的支持。


  多年来我们不断推陈出新,积极倡导“锐意进取、精益求精、信守承诺、探索求新”的企业精神,以“保证质量,提高客户满意度”为经营宗旨,以质量求生存,以品种求发展,以科学技术为先导,致力于中国检验领域的缜密科学。面对未来,我们将一如既往的提供高质量的产品、优惠的价格及优质的服务。并秉持“专业、真诚”的服务宗旨,期待着与您在更为广阔的天地里,成就共同发展,共创双赢的目标!期待着与您的合作!


  我们坚信,只有不断创新,不断进步,我们才有更强大的生命力!


详细信息

Human IGF-I ELISA试剂盒 Mediagnost 背景介绍:

The ELISA E20 is intended to be used for the measurement of human IGF-I in serum and plasma samples. In combination with growth retardation and other clinical symptoms the results of this test system can be used as supplementary data to assess disturbances of the growth hormone axis. 1 INTRODUCTION Insulin-like growth factors (IGF) I and II play a pivotal role in regulating the proliferation, differentiation and specific functions of many cell types (1-3). IGF-I is identical with Somatomedin C (Sm-C) (4) and has a molecular weight of 7649 Dalton (5). Its major regulators are growth hormone (GH) and nutrition (6), although its production in specific tissues is affected by a multitude of tropic hormones and other peptide growth factors. In contrast to many other peptide hormones, IGFs are avidly bound to specific binding proteins (IGFBP). The seven classes of IGFBPs which are known at present (7,8,22) either bind IGF-I and IGF-II with similar affinities or show a preference for IGF-II (9,10). A major problem of IGF-I measurement results from the interference of IGFBPs in the assay. Direct determinations in untreated serum samples (11) give false values because of the extremely slow dissociation of the IGF-I/IGFBP-3 complexes during the assay incubation. Depending on the ratio IGF-I to IGFBP the following errors may occur (see also Figure 1): REF: E20


Human IGF-I ELISA试剂盒 Mediagnost  Therefore, various techniques were applied to physically separate IGF-I from its binding proteins before measurement, including (a) size exclusion chromatography under acidic conditions, (b) solid-phase extraction and (c) acid-ethanol extraction (2,12,13). These techniques, however, are either inconvenient or time-consuming or give incomplete and notreproducible recoveries. The most widely used method is the acid-ethanol extraction (13,14) with a recovery of only 70-80 % of IGFBP-bound IGF-I as a result of co-precipitation. The absolute results of such an extraction are therefore false low (15). The extraction removes the IGFBPs only insufficiently and leads to reduction in sensitivity of the assay due to predilution of the samples by the extraction procedure. Furthermore, the remaining IGFBP may still interfere in the assay. In addition, the acid-ethanol extraction is ineffective in specimens other than serum or plasma (e.g. cell culture media), in which determination of IGF-I is already difficult enough due to the fact that IGFBPs are frequently present at large excess. To avoid these difficulties, an uncomplicated assay was developed, in which special sample preparation is not required before measurement. Clinical Significance There are apart from GH, a number of variables that influence serum IGF-I. Decreased levels are found in states of malnutrition/ malabsorption, hypothyroidism, liver disease, untreated diabetes mellitus, chronic inflammatory disease (1,6), malignant disease or polytrauma. High levels, on the other hand, are likely to be present in precocious puberty or obesity. Crucially important to the correct interpretation of IGF-I measurement is the relationship between age and IGF-I levels (see Table 2 and Fig.: 4-6). Due to its GH-dependence, determination of serum IGF-I was shown to be a useful tool in diagnosis of growth disorders, especially with regard to GH deficiency (GHD) or acromegaly (6,16-19,23,24). The major advantage of IGF–I determination compared to GH determination is its stable circadian concentration; therefore a single measurement is sufficient. Hence IGFI determination should be the first in a series of laboratory test. Clearly normal levels would then rule out disturbances of the GH-IGF-I-axis. Low levels, i.e. close to or below the agerelated 5th percentile would indicate the necessity of further diagnostic efforts. Subnormal levels of IGF-I would be evidence for reduced GH secretion, if other causes of low serum IGF-I (e.g. malnutrition or impaired liver function) can be ruled out. For differentiation of healthy short children without GH deficiency and children with "classical" GH deficiency, the 0.1st percentile proved to be an appropriate cut-off point, especially after the age of eight. However, IGF-I levels of short children not suffering from GHD may nevertheless lay between the 0.1st and 5th percentile (19).

相关技术文章

同类产品推荐

相关分类导航

产品参数

供货周期 现货
货号 E20
应用领域 医疗卫生
企业未开通此功能
详询客服 : 0571-87858618
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :